Riskpilot← Back to searchSign inGet full accessDECON-X INTERNATIONAL AS
ASActiveOrg 989730282Vollsveien 13C, 1366 LysakerOther human health activities n.e.c. · NACE 8699Est. 200612 employeeswww.deconx.com
Revenue 2025
NOK 13,1M
+6% vs 2024
EBITDA margin
4.2%
+156% vs 2024
Equity ratio
39.9%
Financial strength
Net profit 2025
NOK -2,8M
+33% vs 2024
| Revenue | NOK 13,1M | +6% |
| EBITDA | NOK 552K | +156% |
| Net profit | NOK -2,8M | +33% |
| Total assets | NOK 15,1M | -20% |
| Equity | NOK 6M | -32% |
| Employees | 12 | — |
Legal name
DECON-X INTERNATIONAL AS
Org number
989730282
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
25. april 2006
Share capital
NOK 4 172 449
Employees
12 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Salg og levering av tjenester knyttet til dekontaminering, og andre produkter som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretagender.
Address
Vollsveien 13C, 1366 Lysaker
Phone
+4722165160
Email
post@deconx.com
Website
www.deconx.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 12 927 | 13 563 | 11 619 | 12 349 | 13 128 |
| Staff expenses | −8 980 | −8 754 | −9 889 | −6 298 | −6 927 |
| EBITDA | −8 700 | −7 309 | −7 694 | 216 | 552 |
| Depreciation & amort. | −0 | −3 453 | −4 041 | −3 842 | −2 827 |
| EBIT | −8 700 | −10 762 | −11 735 | −3 627 | −2 275 |
| Net financials | −242 | −184 | −521 | −505 | −505 |
| Profit before tax | −8 942 | −10 947 | −12 256 | −4 132 | −2 780 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −8 942 | −10 947 | −12 256 | −4 132 | −2 780 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 32 979 | 33 858 | 25 630 | 18 921 | 15 091 |
| Equity | 18 767 | 19 607 | 12 937 | 8 806 | 6 026 |
| Long-term debt | 9 133 | 8 554 | 7 676 | 6 198 | 5 619 |
| Short-term debt | 5 079 | 5 697 | 5 017 | 3 918 | 3 446 |
| Total debt | 14 212 | 14 251 | 12 693 | 10 116 | 9 065 |
EBITDA margin
4.2%
This company
15.8%
Market median
-73% vs market
20212025
Equity ratio
39.9%
This company
38.2%
Market median
+4% vs market
20212025
Return on equity
-46.1%
This company
18.4%
Market median
-351% vs market
20212025
Net profit margin
-21.2%
This company
8.1%
Market median
-362% vs market
20212025
Asset turnover
0.87×
This company
1.12×
Market median
+22% vs market
20212025
Debt / equity
1.50×
This company
0.62×
Market median
-142% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BP Chief Executive Officer | Chief Executive Officer | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Board of Directors | 2018 – 2022 | |
| Chairman | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 68.61% | 68.61% | 2022 | |
| Company | 4.02% | 4.02% | 2022 | |
| Company | 4.01% | 4.01% | 2022 | |
| Company | 3.7% | 3.7% | 2022 | |
| Company | 3.7% | 3.7% | 2022 | |
| Company | 2.63% | 2.63% | 2022 | |
| Individual | 2.59% | 2.59% | 2022 | |
| Company | 2.59% | 2.59% | 2022 | |
| Company | 1.46% | 1.46% | 2022 | |
Mika Koponen | Company | 1.16% | 1.16% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DECON-X INTERNATIONAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjørn Philip Parrinder Platou | Chief Executive Officer | 0 companies |
| Helge Johan Kjersem | Board of Directors | 0 companies |
| Lars Tormodsgard | Chairman | 0 companies |
| Bjarte Røyrvik | Chairman | 0 companies |
| Hallvard Thonstad | Board of Directors | 0 companies |
| Thor Bendik Weider | Board of Directors | 0 companies |